Welcome to our dedicated page for Fortive SEC filings (Ticker: FTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Multi-segment industrial companies like Fortive Corporation (FTV) pack years of acquisitions, sensing technologies, and field instrumentation data into hundreds of pages. Finding how healthcare sensing margins shifted or when executives sold shares can feel impossible.
Our platform solves that. Stock Titan delivers AI-powered summaries that turn every Fortive annual report 10-K into a plain-English brief and breaks each quarterly earnings report 10-Q filing down to segment-level trends in minutes. Need the exact note on software recurring revenue? We highlight it. Curious about Fortive insider trading Form 4 transactions? Real-time Form 4 insider transactions alerts surface buying and selling activity the moment it hits EDGAR. We also tag every 8-K material event so you instantly see when Fortive closes a bolt-on acquisition.
Browse the complete library—proxy statement executive compensation details, Fortive 8-K material events explained, or an understanding Fortive SEC documents with AI tutorial. Whether you’re tracking Fortive quarterly earnings report 10-Q filing trends, comparing divisions for an earnings model, or scanning Fortive executive stock transactions Form 4 before a board vote, our AI points you straight to the metrics that drive valuations. All filings are updated in real time, and every page is cross-linked for quick navigation, so you spend time acting on insights—not searching for them.
Fortive Corp. (FTV) – Form 4 insider transaction
Chief Financial Officer Mark D. Okerstrom reported an open-market purchase of 21,300 common shares on 01-Aug-2025 at a weighted-average price of $47.03 (price range $46.66–$47.24). The transaction lifts his direct ownership to 94,622 shares.
The share count incorporates additional Restricted Stock Units received through an anti-dilution adjustment tied to Fortive’s recent spin-off of Ralliant Corporation. No derivative securities were involved, and no sales were disclosed.
The filing was submitted by a single reporting person and contains no other material events.
Fortive’s Q2-25 results show modest top-line erosion and margin compression ahead of the Precision Technologies (PT) spin. Revenue slipped 2.2% YoY to $1.52 bn as softer product sales in PT (-5%) offset stable Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). Gross margin eased 80 bp to 59.0%, while operating margin contracted 480 bp to 14.6% on $41 m separation costs and higher SG&A. Net earnings fell 14.6% to $166.6 m; diluted EPS dropped to $0.49 (vs $0.55).
Cash strengthened but leverage ticked up. Operating cash flow of $552.9 m (-2% YoY) plus lower capex lifted cash & equivalents to $1.83 bn from $813 m at FY-24. Total debt rose to $4.81 bn (vs $3.71 bn) with $1.15 bn of new Ralliant term-loans classified as current until the 28 Jun 25 spin. Current debt therefore jumped to $1.91 bn. Net debt/EBITDA remains manageable at ~1.6× (pro-forma).
Strategic actions. On 28 Jun 25 Fortive completed the tax-free distribution of PT as Ralliant, receiving a $1.15 bn dividend which management is using to redeem €252 m of 3.7% notes, repay euro/yen term loans and fund a special share-repurchase program announced 27 May 25. Beginning Q3-25, Ralliant will be reported as discontinued operations, simplifying Fortive to IOS and AHS.
Liquidity & outlook. Undrawn $2.0 bn revolver backs commercial paper ($395 m outstanding). FX-translation gains added $178 m to AOCI. Management continues a discrete restructuring (charges: $12 m YTD) to resize post-spin cost base. No forward guidance was provided in the filing.
Fortive Corporation (FTV) – Form 4 insider transaction
On 07/02/2025 President & CEO Olumide Soroye received a new equity compensation package that includes:
- 33,100 Restricted Stock Units (RSUs) – issued in two tranches of 14,185 and 18,915 units, both time-based; RSUs settle one-for-one in common shares.
- 100,300 stock options – two grants for 42,990 and 57,310 shares at an exercise price of $53.34; options expire 07/02/2035 with multi-year vesting schedules (50 % vests on 3rd & 4th anniversaries for one grant; 50 %, 25 %, 25 % over years 1-3 for the other).
Following the RSU grants, Soroye’s direct ownership increased to 206,130 common shares. Option grants are non-cash awards and do not affect current share count until exercised, but they add to potential future dilution.
The company notes that share totals may be adjusted after the 06/28/2025 spin-off of Ralliant Corporation.
The filing represents routine executive compensation rather than an open-market purchase; market impact is likely limited.
FAQ
What is the current stock price of Fortive (FTV)?
What is the market cap of Fortive (FTV)?
